Form 8-K Colgate Palmolive Co

Current report, item 8.01

Published: 2019-09-20 16:30:49
Submitted: 2019-09-20
Period Ending In: 2019-09-19
a52098642.htm COLGATE-PALMOLIVE COMPANY 8-K


>
false000002166500000216652019-09-192019-09-190000021665cl:CommonStock100ParValueMember2019-09-192019-09-190000021665cl:Zero500NotesDue2026Member2019-09-192019-09-190000021665cl:One375NotesDue2034Member2019-09-192019-09-19
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC  20549
________________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) September 20, 2019 (September 19, 2019)
COLGATE PALMOLIVE COMPANY
 (Exact name of registrant as specified in its charter)

Delaware
1-644
13-1815595
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)

300 Park Avenue, New York, New York 10022
(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code (212) 310-2000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
  Trading Symbol(s)
 
Name of each exchange on which
registered
Common Stock, $1.00 par value
  CL
  New York Stock Exchange
0.500% Notes due 2026
  CL 26
  New York Stock Exchange
1.375% Notes due 2034
  CL 34
  New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01.
Other Events.
 
On September 19, 2019, Colgate-Palmolive Company (“Colgate”) completed its previously announced acquisition of Laboratoires Filorga Cosmétiques, pursuant to a Share Purchase Agreement, dated as of July 11, 2019, by and between Colgate and Filorga Initiatives, for a cash purchase price of approximately €1,516 million (approximately US$ 1,674 million), which includes interest on the previously disclosed equity purchase price.

SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
COLGATE-PALMOLIVE COMPANY
 
 
 
 
 
 
 
 
 
 
 
 
 
By:
/s/ Jennifer M. Daniels
 
Name:
Jennifer M. Daniels
 
Title:
Chief Legal Officer and Secretary


Date:  September 20, 2019
Additional Files
FileSequenceDescriptionTypeSize
0001157523-19-001990.txt   Complete submission text file   210322
cl-20190919.xsd 2 XBRL TAXONOMY EXTENSION SCHEMA EX-101.SCH 5230
cl-20190919_def.xml 3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.DEF 18695
cl-20190919_lab.xml 4 XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.LAB 28858
cl-20190919_pre.xml 5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EX-101.PRE 20995
a52098642_htm.xml 11 EXTRACTED XBRL INSTANCE DOCUMENT XML 7146

© 2019 SEC.report
SEC CFR Title 17 of the Code of Federal Regulations.